Pure Red Cell Aplasia Following Interleukin-2 Therapy

A 61-year-old woman with metastatic renal cell carcinoma underwent systemic treatment with high-dose interleukin-2 (IL-2). Anemia requiring transfusion of 1 unit of packed red blood cells (PRBCs) was required during the second week of IL-2 therapy. One month following completion of high-dose IL-2 tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutcher, Janice P., Fan, Wen, Wiernik, Peter H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840614/
https://www.ncbi.nlm.nih.gov/pubmed/27144182
http://dx.doi.org/10.1177/2324709616643991

Ejemplares similares

Ejemplares similares